Marieke C. Bolling

Groningen, GR 9700RB, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapies.

Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapies.

Journal: Molecular therapy. Nucleic acids

Published: July 01, 2026

The Economic Burden of Epidermolysis Bullosa: A Scoping Review.

The Economic Burden of Epidermolysis Bullosa: A Scoping Review.

Journal: Dermatology (Basel, Switzerland)

Published: February 01, 2026

VEXAS syndrome as an underlying cause of disease in patients with Sweet syndrome.

VEXAS syndrome as an underlying cause of disease in patients with Sweet syndrome.

Journal: JAAD case reports

Published: December 03, 2025

Sublingual tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a randomized, placebo-controlled crossover study.

Sublingual tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a randomized, placebo-controlled crossover study.

Journal: The British journal of dermatology

Published: November 02, 2025

Classifying novel DSG1 variants on disease severity in SAM syndrome and palmoplantar keratoderma.

Classifying novel DSG1 variants on disease severity in SAM syndrome and palmoplantar keratoderma.

Journal: Journal of dermatological science

Published: October 17, 2025

Novel ATP2C1 genetic variants in a Dutch cohort of patients with Hailey-Hailey disease.

Novel ATP2C1 genetic variants in a Dutch cohort of patients with Hailey-Hailey disease.

Journal: Journal of dermatological science

Published: June 13, 2025

Recessive epidermolysis bullosa simplex due to EXPH5 variants: case series of a rare subtype with multiple faces.

Recessive epidermolysis bullosa simplex due to EXPH5 variants: case series of a rare subtype with multiple faces.

Journal: The British journal of dermatology

Published: April 30, 2025

Long-read sequencing cracks unsolved cases and further improves genome diagnostics in epidermolysis bullosa.

Long-read sequencing cracks unsolved cases and further improves genome diagnostics in epidermolysis bullosa.

Journal: Journal of dermatological science

Published: April 01, 2025

SOX2 Is a Potential Diagnostic Biomarker and Anticancer Target in Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa: A Case Series Study.

SOX2 Is a Potential Diagnostic Biomarker and Anticancer Target in Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa: A Case Series Study.

Journal: JID innovations : skin science from molecules to population health

Published: February 11, 2025

Outcome measurement in pemphigus clinical research: a scoping review on heterogeneity in outcome reporting and definitions.

Outcome measurement in pemphigus clinical research: a scoping review on heterogeneity in outcome reporting and definitions.

Journal: The British journal of dermatology

Published: November 30, 2024

Systematic review on antipruritic therapies for patients with Epidermolysis bullosa.

Systematic review on antipruritic therapies for patients with Epidermolysis bullosa.

Journal: The Journal of dermatological treatment

Published: July 28, 2024

Long-term remission of Hailey-Hailey disease by Er:YAG ablative laser therapy.

Long-term remission of Hailey-Hailey disease by Er:YAG ablative laser therapy.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 22, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026